NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/10/2026
Back to search
Official data from USPTO
RYPLAZIM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
48
Latest update
08/06/2026
Trademark type
Word
Nice classes
5
Filing date
11/25/2016
Registration date
12/10/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2026
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
03
Owner location
FORT LEE, NJ, US
Examiner
WATTS-FITZGERALD, CAITLIN C
Current location
Historical data usage
Holders and representatives
Holders
KEDRION BIOPHARMA INC.
ProMetic BioTherapeutics, Inc.
Representatives
Lindsay Jones Merchant & Gould P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of conditions associated with plasminogen deficiencies
Publications
History of USPTO decisions and trademark events.
48 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/10/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2026
E815
TEAS SECTION 8 & 15 RECEIVED
12/08/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/10/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/06/2023
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
11/29/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/29/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/29/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/29/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/29/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/29/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/10/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/24/2019
PUBO
PUBLISHED FOR OPPOSITION
09/24/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/04/2019
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/16/2019
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
08/09/2019
APET
ASSIGNED TO PETITION STAFF
08/09/2019
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
07/10/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/05/2019
EX4G
SOU EXTENSION 4 GRANTED
06/03/2019
EXT4
SOU EXTENSION 4 FILED
06/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/14/2018
EX3G
SOU EXTENSION 3 GRANTED
12/12/2018
EXT3
SOU EXTENSION 3 FILED
12/12/2018
EEXT
SOU TEAS EXTENSION RECEIVED
12/12/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/11/2018
EX2G
SOU EXTENSION 2 GRANTED
05/09/2018
EXT2
SOU EXTENSION 2 FILED
05/09/2018
EEXT
SOU TEAS EXTENSION RECEIVED
05/09/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/13/2017
EX1G
SOU EXTENSION 1 GRANTED
10/11/2017
EXT1
SOU EXTENSION 1 FILED
10/11/2017
EEXT
SOU TEAS EXTENSION RECEIVED
10/11/2017
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/21/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/25/2017
PUBO
PUBLISHED FOR OPPOSITION
04/25/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/03/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
03/03/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/03/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
03/03/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/03/2017
DOCK
ASSIGNED TO EXAMINER
03/01/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2016
NWAP
NEW APPLICATION ENTERED
11/29/2016
Continuous trademark protection
Get notified about every new filing that threatens RYPLAZIM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.